|
"...quite remarkable... 1 year experiment of age reversing with epigenetics..."
|
1
|
Resverlogix Corp.
|
Feb 03, 2023 10:42AM
|
|
CityNews cover
|
9
|
Resverlogix Corp.
|
Jan 31, 2022 09:20AM
|
|
COVID-19 treatment with RVX
|
8
|
Resverlogix Corp.
|
Apr 12, 2021 02:27PM
|
|
Epigenetics and Aging: The effects of DNA breakage and repair
|
3
|
Resverlogix Corp.
|
Jan 28, 2023 09:44PM
|
|
Long COVID symptoms linked to inflammation
|
9
|
Resverlogix Corp.
|
Jun 28, 2022 06:06PM
|
|
Re: "Actively Recruiting" ?
|
13
|
Resverlogix Corp.
|
Nov 09, 2021 03:41PM
|
|
Re: A look at the competition.
|
3
|
Resverlogix Corp.
|
May 17, 2021 09:28PM
|
|
Re: By the time….
|
10
|
Resverlogix Corp.
|
Mar 02, 2022 12:52PM
|
|
Re: Ethics
|
3
|
Resverlogix Corp.
|
May 13, 2021 09:44PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
8
|
Resverlogix Corp.
|
Apr 05, 2022 01:56PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
8
|
Resverlogix Corp.
|
Apr 05, 2022 06:04PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
5
|
Resverlogix Corp.
|
Apr 05, 2022 06:13PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
7
|
Resverlogix Corp.
|
Apr 05, 2022 08:13PM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
9
|
Resverlogix Corp.
|
Apr 06, 2022 08:48AM
|
|
Re: FDA approves "empagliflozin" for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients
|
6
|
Resverlogix Corp.
|
Apr 05, 2022 12:07PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
4
|
Resverlogix Corp.
|
Apr 13, 2021 02:19PM
|
|
Re: Here is the example of the danger of the COVID trial to RVX...
|
5
|
Resverlogix Corp.
|
Nov 11, 2021 01:22PM
|
|
Re: Long Covid
|
5
|
Resverlogix Corp.
|
Jan 22, 2024 10:37AM
|
|
Re: Long Covid
|
6
|
Resverlogix Corp.
|
Jan 22, 2024 03:23PM
|
|
Re: Long Covid
|
5
|
Resverlogix Corp.
|
Jan 22, 2024 03:40PM
|
